News Centermore
-
Hanmi proves global competiveness for obesity, diabetes, NASH treatment
Jun 24, 2019
-
“Belvarafenib showed activity in patients with solid tumors harboring mutations for which no targeted therapies are approved”
Jun 10, 2019
-
Why do foreign delegations pay visit to Hanmi’s ‘Smart Plant’?
Mar 28, 2019
-
Athenex Announces FDA Allowance of Investigational New Drug Application of Eribulin ORA to Begin Clinical Trials.
Oct 30, 2018
-
“Evolution of LAPSCOVERY”…Apply to diabetes, obesity, NASH and rare disease.
Oct 10, 2018
AMOSARTAN TAB.5/50mg
Esomezol cap.
PalPal tab.
Pidogul tab.
Fluterol inhalation powder
Hyalrheuma Inj.
Triaxone inj.
Muco Gard